Dr. Jianjun ZOU, General Manager and CEO of Junshi Biosciences, said, "Toripalimab's approval in Singapore represents our ...

LENZ Therapeutics, Inc.'s LNZ100 eye drops show strong phase 3 results for presbyopia, outperforming competitors. Click here ...

Aquestive's Anaphylm, which is set for an imminent FDA filing, has blockbuster potential. See why I think AQST stock is a buy ...

Isro successfully completed a rolling experiment with its Space Docking Experiment mission, involving circumnavigation of one ...

Liquidia (LQDA) announced that the U.S. Food and Drug Administration has accepted its New Drug Application resubmission for YUTREPIA inhalation ...

Shai Biran; Investor Relations; Spero Therapeutics Inc. Esther Rajavelu; Interim President, Interim Chief Executive Officer, Chief Financial Officer, Treasurer, Chief Business Officer; Spero ...

Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., March 27, 2025. REUTERS/Brendan McDermid A rocky U.S. stock market will be tested in the coming week by a ...

Organizations struggle to inventory and manage NHIs at scale and address the root cause of risk: secret exposure. As part of its Complete ASPM platform, Cycode empowers you to fix the NHI risks that ...

CHICAGO — In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular thrombus had comparable outcomes at 3 months to patients treated ...